Insider Trading
| PALI Stock | USD 1.02 0.02 1.92% |
Under 62% of Palisade Bio's investor base is looking to short. The analysis of overall sentiment of trading Palisade Bio stock suggests that many investors are alarmed at this time. Palisade Bio's investing sentiment shows overall attitude of investors towards Palisade Bio.
Filed transaction by Palisade Bio Director: . Insider Public Trading
Read at macroaxis.com
Palisade Bio Fundamental Analysis
We analyze Palisade Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Palisade Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Palisade Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Palisade Bio is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Palisade Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Palisade Bio stock to make a market-neutral strategy. Peer analysis of Palisade Bio could also be used in its relative valuation, which is a method of valuing Palisade Bio by comparing valuation metrics with similar companies.
Peers
Palisade Bio Related Equities
| ZURA | Zura Bio | 7.53 | ||||
| ATNF | 180 Life | 5.66 | ||||
| ENSC | Ensysce Biosciences | 3.72 | ||||
| CDIO | Cardio Diagnostics | 0.50 | ||||
| PHIO | Phio Pharmaceuticals | 0.84 | ||||
| MTVA | MetaVia | 1.64 | ||||
| QNRX | Quoin Pharmaceuticals | 1.76 | ||||
| KPRX | Kiora Pharmaceuticals | 2.31 | ||||
| SONN | Sonnet Biotherapeutics | 5.69 | ||||
| NUWE | Nuwellis | 21.18 |
Complementary Tools for Palisade Stock analysis
When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |